Animal Technician

Summary

We are seeking a motivated Animal Technician to join our team at ARTBIO at our ARTOslo office. As a key member of our In Vivo Biology team, you will support in vivo pharmacology efforts and contribute to the advancement of targeted radioligand therapies.

Responsibilities

• Monitor animal health, to recognize, predict and interpret animal responses.
• Play a key role in selecting animals for studies and refining animal assessment, dosing, and sampling techniques.
• Support all scientific research entities on in vivo pharmacology assessments of radiopharmaceuticals (i.e., disease model testing, PK, PD and toxicology studies, and molecular imaging).
• Perform routine parts of experiments including giving injections, administering medicines, tissue collection and processing, blood, urine, and stool sample analysis.
• Collect and maintain data records.
• Perform routine maintenance of laboratory, instruments, and equipment according to established procedures.
• Manage animal laboratory inventory including managing the ordering of animals and lab supplies.

Qualifications & Education

• Bachelor’s degree, diploma or certified training in animal science, animal technology, animal management, animal care or related field.
• At least 1 year experience working with research animals (rodents) with good technical knowledge on animal handling and multiple routes of drug administration.
• Good understanding of the requirements of Animal Welfare regulations which govern the use of animals in scientific research.
• Certification to work with research animals i.e FELASA/ CAREiN.
• Excellent written and verbal communication skills.
• Excellent organizational and problem-solving skills.
• Experience in in vivo molecular imaging (added advantage).
• Experience working with open-source radionuclides (added advantage).

About Us
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first in human trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit www.artbio.com, and follow us on LinkedIn and Twitter. 

As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work.  We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration. 

EEO Statement
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.

---